Status:
WITHDRAWN
Does Letrozole Improve the Outcomes and/or Reduce the Cost of IVF-ET Cycles?
Lead Sponsor:
Center for Human Reproduction
Conditions:
Infertility
Eligibility:
FEMALE
21-38 years
Phase:
PHASE4
Brief Summary
This research is being done to determine whether the success rate of in vitro fertilization treatment can be improved, while lowering the cost incurred from infertility medications using a pill called...
Detailed Description
Specific Aim: 1. To determine whether addition of letrozole to gonadotropins would reduce the amount of gonadotropins used in an IVF-ET cycle, thereby reducing the cost. 2. To determine whether letro...
Eligibility Criteria
Inclusion
- Normal Ovarian Function
- Normal uterus
Exclusion
- Age 40 and above
- Diminished ovarian reserve (based on markers and/or previous poor response)
- Previous oophorectomy
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00804960
Start Date
September 1 2008
End Date
April 1 2010
Last Update
June 25 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Human Reproduction
New York, New York, United States, 10021